Darling Ingredients (DAR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Achieved net income of $134.3 million ($0.83 per diluted share) in Q1 2026, reversing a net loss of $26.2 million ($-0.16 per share) in Q1 2025.
Total net sales rose to $1.6 billion, up from $1.4 billion year-over-year, with strong margin expansion and improved earnings power.
Combined Adjusted EBITDA more than doubled to $406.8 million from $195.8 million year-over-year.
Focused on operational excellence, disciplined capital allocation, and meaningful debt reduction amid volatile commodity markets.
Monetized $45 million in Production Tax Credit sales, enhancing liquidity.
Financial highlights
Gross margin improved to $404.9 million (26.1%), up from $311.4 million (22.6%) year-over-year.
Operating income surged to $226.8 million from $28.4 million year-over-year.
Cash and cash equivalents at $116 million; total debt at $4.1 billion as of April 4, 2026.
Preliminary leverage ratio at 3.17x, up from 2.9x at year-end 2025.
Capital expenditures for Q1 2026 were $94.8 million.
Outlook and guidance
Q2 2026 core ingredients business Adjusted EBITDA expected at $260–275 million.
Expect continued EBITDA growth and margin expansion, with DGD projected to deliver stronger results in Q2 and Q3.
Effective tax rate for 2026 expected around 25%, with $60 million in cash taxes for the remainder of the year.
Improving fat and fuel prices anticipated to support Q2 segment outlook.
FY 2026 capital expenditures estimated at $400 million.
Latest events from Darling Ingredients
- Q4/FY2025 sales and margins rose, but net income fell sharply on restructuring charges.DAR
Q4 202512 Apr 2026 - Shareholders will vote on directors, auditor, executive pay, and a new incentive plan amid strong 2025 results.DAR
Proxy filing19 Mar 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and incentive plan.DAR
Proxy filing19 Mar 2026 - Global leader in animal byproduct repurposing, poised for growth in food, feed, and renewables.DAR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Net income and sales declined sharply in Q2, but EBITDA guidance and margin focus remain.DAR
Q2 20242 Feb 2026 - Bullish 2026 outlook with policy clarity, JV expansion, and strong growth in renewables and collagen.DAR
Jefferies Renewables & Clean Energy Conference22 Jan 2026 - Net loss of $26.2M, lower DGD earnings, but 2025 EBITDA guidance reaffirmed and debt reduced.DAR
Q1 202522 Jan 2026 - Q3 2024 net income dropped to $16.9M, but 2025 outlook is strong with regulatory tailwinds.DAR
Q3 202418 Jan 2026 - Global leader in animal byproducts and renewable fuels, poised for growth amid strong regulatory support.DAR
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20255 Jan 2026